NeurologyLive Friday 5 - August 28, 2020


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 28, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Marwan Sabbagh, MD: How Aducanumab Impacts Future Studies

The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic discussed how Alzheimer disease research may change if aducanumab becomes approved.


2: Mind Moments Podcast, Ep. 16: Personalizing Our Approach to Medication Adherence in Parkinson Disease

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Rajesh Pahwa, MD, on the challenges of medication adherence in Parkinson disease.


3: Cognitive Behavioral Therapy for Insomnia Shows Multiple Benefits for Women

Multiple abstracts at SLEEP 2020 show CBT-I’s success in aiding women with insomnia, including women who are pregnant and female veterans both with and without PTSD.


4: How Access to SMA Therapy Will Alter Disease Management As We Know It

Efforts to cut through regulatory red tape will help ensure earlier access to potentially lifesaving treatments for patients with spinal muscular atrophy.


5: AAN 2020 Data Release: Ofatumumab for Relapsing MS

Ravi Dukkipati, MD, discusses the data released at the AAN 2020 Annual Meeting regarding the use of ofatumumab in managing relapsing multiple sclerosis.


Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.